News and analysis on disease research and diagnostics.
The lab analytics service provides insurers with guidance aimed at helping them achieve improvements in quality performance metrics.
A new analysis of the study yielded mixed news for black women, confirming that they suffer worse outcomes, even with the same genetic test results and treatment.
The partners will identify patients with gastrointestinal or endometrial cancers who may benefit from immune checkpoint inhibitor therapy using Biotype's technology.
Plans are in place for a Guardant360-based assay to predict response to AsztraZeneca's Tagrisso and for a blood-based TMB test using the larger GuardantOmni panel.
A technology called Stratification of Adverse Pathology, or STRAT-AP shows potential to risk-stratify patients using phenotypic biomarkers.
